A furious row has broken out between a drugs company and the NHS regulator in England over the price of a new breast cancer treatment.
Kadcyal which is manufactured by Roche Products Limited can give patients with HER2-positive breast cancer an additional six months of life, but the regulator deemed it too expensive.
ITV News correspondent Nina Nannar reports.
More top news
PM spokesman's comments come following reports that the EU is secretly drawing up plans for greater military cooperation across the EU.
The Labour politicians put their alleged differences aside to jointly highlight how remaining in the EU could help fight climate change.
Late sunshine here and there this evening - but more cloud for southern Scotland, northern England and Northern Ireland again.